Home
Companies
Ipsen
Clinical Trials

Clinical Trials Related to Ipsen

Related studies linked through entity extraction aliases.

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)

Status: COMPLETED
Phase: N/A

Dysport in Post-Surgical Neuralgia

Status: COMPLETED
Phase: PHASE2

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Dysport in Vulvodynia Phase II Study

Status: TERMINATED
Phase: PHASE2

Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis

Status: COMPLETED
Phase: N/A

" Treating MS Patients With Lower Extremity Spasticity Using Dysport"

Status: UNKNOWN
Phase: PHASE3

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Status: COMPLETED
Phase: PHASE2

Efficacy, Safety and Tolerability of a New Bowel Cleansing Preparation (BLI800) in Adult Subjects Undergoing Colonoscopy

Status: COMPLETED
Phase: PHASE3

Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel

Status: COMPLETED
Phase: N/A

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Status: TERMINATED
Phase: PHASE1

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

Status: COMPLETED
Phase: N/A

Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment

Status: UNKNOWN
Phase: PHASE2

A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function

Status: COMPLETED
Phase: PHASE1

Validation of the Spasticity Related Quality of Life Questionnaire

Status: COMPLETED
Phase: NA

Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)

Status: COMPLETED
Phase: PHASE1/PHASE2

Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

Status: COMPLETED
Phase: N/A

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Neuro-Orthopedic Registry of the University Hospital of Toulouse

Status: COMPLETED
Phase: N/A